$
₹
$1.01—% (+1.01)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
1D
1W
1M
1Y
5Y
Max
Key Metrics
Key Metrics
PE TTM
PE TTM
Close price divided by the earnings per share for the trailing twelve months
0.00
PB
PB
Close price divided by the book value per share at the end of the most recent quarter
0.93
EPS TTM
EPS TTM
Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)
$325
PEG Ratio
PEG Ratio
Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years
—
Profit Margin
Profit Margin
Net profit divided by the total revenue for the most recent financial year
0%
Dividend Yield
Dividend Yield
Annual dividend per share for the trailing twelve months divided by the close price
—
Analyst Ratings & ForecastAnalyst Ratings & Forecast
Analyst Ratings & Forecast
Analyst Ratings & Forecast
Based on 1 analyst's reports
Buy1 analyst
Hold0 analyst
Sell0 analyst
Analysts expect a +6196.30% price upside over the next year
Current Price$1.01
Target Price$85
Company Profile
Peers
Peers
ABBV
P/E Ratio
106.43
106.43
1Y Return
21.98%
21.98%
Buy Reco %
57.14
57.14
AMGN
P/E Ratio
23.53
23.53
1Y Return
23.62%
23.62%
Buy Reco %
46.87
46.87
P/E Ratio
17.54
17.54
1Y Return
18.57%
18.57%
Buy Reco %
63.33
63.33
P/E Ratio
25.45
25.45
1Y Return
0.67%
0.67%
Buy Reco %
52.94
52.94
P/E Ratio
15.10
15.10
1Y Return
31.9%
31.9%
Buy Reco %
76.00
76.00
Peers & Comparison
Peers & Comparison
Valuation
Returns
Forecast
| Stock | PE TTMPE TTM | PBPB | PEG RatioPEG Ratio |
|---|---|---|---|
| Revelation Biosciences Inc | 0.00 | 0.93 | - |
| AbbVie Inc | 106.43 | 50.45 | 0.58 |
| Amgen Inc | 23.53 | 19.27 | 2.16 |
Price Comparison
Price Comparison
1 Month
1 Year
5 Years
Financials
Financials
Income
Balance Sheet
Cash Flow
Quarterly Normal View
Hmm, looks like data is currently unavailable. Once it's updated, you can view it here
